Talk of nuclear war has been putting many people on high alert since the Russian invasion of Ukraine in February, causing potassium iodide tablet sales to skyrocket. At least one supplier Anbex reports it is currently out of stock though a new supply of IOSAT Potassium Iodide in 130mg and 65mg doses is expected in April. The product is billed as the “only full-strength radio-protective KI [potassium iodide] tablet that has been approved by the FDA and passed all requirements for purity, quality, safety, and efficacy. For use by adults and children in a radiation emergency.” SERB/BTG/Veriton Specialty Pharmaceuticals, maker of FDA-approved ThyroSafe, also has seen a large and sudden increase in demand for its potassium iodide products globally—and especially in Europe and the United States. “This has coincided with the conflict in Ukraine. I believe news of fighting around Chernobyl and the Zaporizhzhia nuclear power plant contributed to the …